Gender difference as a prognostic factor in patients with non-small cell lung cancer

被引：0
|
作者：
Kim, H. [1 ]
Uhm, J. [1 ]
Ahn, H. [1 ]
Yi, J. [1 ]
Han, J. [1 ]
Choi, Y. [1 ]
Kim, K. [1 ]
Kim, H. [1 ]
Ahn, J. [1 ]
Ahn, M. [1 ]
Park, K. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.22155
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22155
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non-Small Cell Lung Cancer
    Yotsukura, Masaya
    Ohtsuka, Takashi
    Kaseda, Kaoru
    Kamiyama, Ikuo
    Hayashi, Yuichiro
    Asamura, Hisao
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : 1311 - 1318
  • [32] Diabetes is a Negative Prognostic Factor in Non-Small Cell Lung Cancer Patients Undergoing Resectional Surgery
    Yasar, I.
    Sengii, E.
    Sozen, B.
    Kara, H. V.
    Kaynak, K.
    Turna, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S848 - S848
  • [33] Prognostic factor of patients with advanced non-small cell lung cancer receiving best supportive care
    Kishikawa, Takayuki
    Masuda, Shingo
    Oda, Shinya
    Yamaguchi, Keisuke
    Furusato, Yuichiro
    Furusato, Ayaka
    Yamaguchi, Shota
    Inoue, Shigehiro
    Yasaka, Takahiro
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
    Kentaro Miura
    Kazutoshi Hamanaka
    Tomonobu Koizumi
    Satoshi Kawakami
    Nobutaka Kobayashi
    Ken-ichi Ito
    Journal of Cardiothoracic Surgery, 14
  • [35] Perioperative anemia as prognostic factor in patients undergoing resection for non-small cell lung cancer.
    Berardi, R
    Tamburrano, T
    Fianchini, A
    Verdecchia, L
    Onofri, A
    Santinelli, A
    Scartozzi, M
    Cellerino, R
    Cascinu, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 660S - 660S
  • [36] Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients
    Miura, Kentaro
    Hamanaka, Kazutoshi
    Koizumi, Tomonobu
    Kawakami, Satoshi
    Kobayashi, Nobutaka
    Ito, Ken-ichi
    JOURNAL OF CARDIOTHORACIC SURGERY, 2019, 14 (1)
  • [37] Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer
    Chen, Kuan-Bing
    Xuan, Ying
    Shi, Wen-Jun
    Chi, Feng
    Xing, Rui
    Zeng, Yue-Can
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (04): : 1903 - 1909
  • [38] Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer
    Li, HX
    Zhang, S
    Lei, DS
    Wang, XQ
    Skog, S
    He, Q
    ONCOLOGY REPORTS, 2005, 13 (01) : 145 - 149
  • [39] The ABO Blood Group is an Independent Prognostic Factor in Patients With Resected Non-small Cell Lung Cancer
    Fukumoto, Koichi
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Kawaguchi, Koji
    Fukui, Takayuki
    Ishiguro, Futoshi
    Nakamura, Shota
    Yokoi, Kohei
    JOURNAL OF EPIDEMIOLOGY, 2015, 25 (02) : 110 - 116
  • [40] Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer
    Miso Kim
    Hyun Chang
    Hee Chul Yang
    Yu Jung Kim
    Choon-Taek Lee
    Jae-Ho Lee
    Sanghoon Jheon
    Kwhanmien Kim
    Jin-Haeng Chung
    Jong Seok Lee
    World Journal of Surgical Oncology, 12
12345